Moreover, DSF treatment can increase the expression of metalloproteinase 10 (ADAM10) in peripheral blood cells of AD mice, suggesting that DSF can be repurposed as an ADAM10 enhancer and a therapeutic approach for AD.258. Here, ADAM10 is linked to Alzheimer disease.